Validation of the 3D-CAM to Detect Postoperative Delirium

January 16, 2018 updated by: Claudia Spies, Charite University, Berlin, Germany

Validation of the 3D-CAM in the Recovery Room to Detect Postoperative Delirium Compared to Nu-DESC, CAM and DSM-5 Criteria

The 3D-CAM is a new 3-minute diagnostic assessment for Confusion Assessment Method-defined Delirium. The primary objective of this study is to translate the 3D-CAM into the German language, as well as to validate its use to detect postoperative delirium in the recovery room. The validation will be based on comparisons to the Nu-DESC (Nursing Delirium Screening Scale), CAM (Confusion Assessment Method), and DSM-5 criteria (Diagnostic and Statistical Manual of Mental Disorders).

Study Overview

Status

Completed

Detailed Description

Approximately 200 patients will be enrolled in the study. They will followed up until the third postoperative day.

Calculation and analysis of demographic and perioperative influencing factors on postoperative delirium according to routine parameters (age, sex, body height, body weight, diagnosis, physical status according to the American Society of Anaesthesiologists (ASA PS), duration of surgery, Physiological and Operative Severity Score (POSSUM), type of anesthesia, medication against pain and delirium) will be performed.

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, 13353
        • Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow - Klinikum, Charite University, Berlin, Germany

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Male and female adult patients undergoing elective general anaesthesia.

Description

Inclusion criteria:

  • Male and female patients with age ≥ 18 years
  • Admission to recovery room (RR) or post anaesthesia care unit (PACU) following elective general anaesthesia and scheduled
  • Inpatient treatment not less than 24 hours.

Exclusion criteria:

  • Patients with psychiatric diseases and mental retardation
  • Analphabetism
  • Anacusis or Hypoacusis with hearing aid device,
  • Amaurosis
  • Lacking willingness to save and hand out data within the study
  • Accommodation in an institution due to an official or judicial order
  • Patients with unability speaking German or English language
  • Participation in other clinical studies during the study period
  • Coworker in the study site

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Patients undergoing elective general anaesthesia
Male and female adult patients undergoing elective general anaesthesia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sensitivity of the delirium screening/diagnosing tool "3D Confusion Assessment Method (3D-CAM)
Time Frame: Up to three days
Sensitivity of the delirium screening/diagnosing tool "3D Confusion Assessment Method (3D-CAM)" to detect postoperative delirium (POD) in the recovery room - Used reference standard: DSM-5 criteria
Up to three days
Specificity of the delirium screening/diagnosing tool "3D Confusion Assessment Method (3D-CAM)
Time Frame: Up to three days
Specificity of the delirium screening/diagnosing tool "3D Confusion Assessment Method (3D-CAM) to detect postoperative delirium (POD) in the recovery room - Used reference standard: DSM-5 criteria
Up to three days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Test Quality Level
Time Frame: Up to three days
Comparison of test Quality level between 3D-CAM, Nu-DESC and CAM to detect POD in the recovery room.
Up to three days
Duration of postoperative delirium
Time Frame: Up to three days
Up to three days
Duration of stay in recovery room
Time Frame: Up to three days
Up to three days
Duration of performance of the delirium testings
Time Frame: Up to three days
Up to three days
Pain level
Time Frame: Participants will be followed up until the third postoperative day
Participants will be followed up until the third postoperative day
Postoperative complications
Time Frame: Up to three days
Postoperative complications according to Clavien-Dindo classification
Up to three days
Duration of hospital stay
Time Frame: Participants will be followed for the duration of hospital stay an expected average of 3 weeks
Participants will be followed for the duration of hospital stay an expected average of 3 weeks
In-house mortality
Time Frame: Participants will be followed for the duration of hospital stay an expected average of 3 weeks
Participants will be followed for the duration of hospital stay an expected average of 3 weeks
Follow-up care
Time Frame: Participants will be followed for the duration of hospital stay an expected average of 3 weeks
Participants will be followed for the duration of hospital stay an expected average of 3 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 9, 2017

Primary Completion (Actual)

January 4, 2018

Study Completion (Actual)

January 5, 2018

Study Registration Dates

First Submitted

December 8, 2016

First Submitted That Met QC Criteria

December 12, 2016

First Posted (Estimate)

December 14, 2016

Study Record Updates

Last Update Posted (Actual)

January 18, 2018

Last Update Submitted That Met QC Criteria

January 16, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Delirium

3
Subscribe